Timothy Kwang Yong Tay

机构：SingHealth, Singapore General Hospital, SingHealth Duke-NUS Academic Medical Centre, Michigan Cancer Research Consortium, Clinical Research Consortium, National Patient Safety Foundation · ORCID：0000-0001-8592-5018

发表论文 83 篇 · 总被引 847 次 · h-index 15

代表论文

• Functional combinatorial precision medicine for predicting and optimizing soft tissue sarcoma treatments (2025 · npj Precision Oncology · 被引 6)
• Ethnic differences in non-metastatic breast cancer outcomes by tumour subtype: Real-world data from the Singapore Joint Breast Cancer Registry. (2025 · Journal of Clinical Oncology · 被引 1)
• Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations (2026 · Therapeutic Advances in Medical Oncology)
• Endometrial Mesonephric-like Carcinosarcoma With Shared KRAS, TP53, and RB1 Mutations: Report of a Rare Case Highlighting Diagnostic Challenges and Novel Molecular Insights, and Review of the Literature (2026 · International Journal of Gynecological Pathology)
• Abstract P22: Decoding ecDNA in Breast Cancer: From Patient-Derived Models to AI-Enhanced Clinical Detection (2026 · Cancer Research)
• Abstract LT01: Spatial Phenotypes Ascribed to Cancers with Extreme Resistance (SPACER) in HR+ HER2- Metastatic Breast Cancer – a Multi-Institutional Use-Case Study of the Translational Research Integration and Support Platform by the Singapore Translational Cancer Consortium (STCC) (2026 · Cancer Research)